Aerovate Therapeutics Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for Aerovate Therapeutics stock have an average target of 11.75, with a low estimate of 2.00 and a high estimate of 41. The average target predicts an increase of 364.43% from the current stock price of 2.53.

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$2.00	$11.75	$2.00	$41
Change	-20.95%	+364.43%	-20.95%	+1520.6%

* Price targets were last updated on Jun 18, 2024.

Analyst Ratings

The average analyst rating for Aerovate Therapeutics stock from 7 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	0	0	0	0	0	0
Buy	1	1	1	1	1	1
Hold	6	6	6	6	6	6
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	7	7	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Liisa Bayko Evercore ISI Group	Evercore ISI Group	Buy → Hold Downgrades $27 → $2	Buy → Hold	Downgrades	$27 → $2	-20.95%	Jun 18, 2024
Vamil Divan Guggenheim	Guggenheim	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Jun 18, 2024
Tiago Fauth Wells Fargo	Wells Fargo	Buy → Hold Downgrades $35 → $2	Buy → Hold	Downgrades	$35 → $2	-20.95%	Jun 18, 2024
Joseph Thome TD Cowen	TD Cowen	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Jun 18, 2024
Eun Yang Jefferies	Jefferies	Strong Buy → Hold Downgrades $65 → $2	Strong Buy → Hold	Downgrades	$65 → $2	-20.95%	Jun 17, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-0.70

from -2.44

EPS Next Year

-2.51

from -0.70

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028	FY 2029
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028	Dec 31, 2029
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-	-	-	-
EPS	-40.31	-1.87	-2.10	-2.87	-2.44	-0.70	-2.51	-
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	5	4	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	n/a	n/a	n/a
Avg	n/a	n/a	n/a
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

EPS Forecast

EPS	2025	2026
High	-0.41	-1.67
Avg	-0.70	-2.51
Low	-1.11	-3.27

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.